X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Price:
42.78
USD
-4.76%
Market Closed
Market Cap:
$3.3B
Relative Value
The Relative Value of one XENE stock under the Base Case scenario is hidden USD. Compared to the current market price of 42.78 USD, Xenon Pharmaceuticals Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
XENE Relative Value
HIDDEN
Multiples Across Competitors
XENE Competitors Multiples
Xenon Pharmaceuticals Inc Competitors
Xenon Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
X
|
Xenon Pharmaceuticals Inc
NASDAQ:XENE
|
3.3B USD | 436 | -10.7 | -8.3 | -8.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
407.7B USD | 6.7 | 97.4 | 16 | 22.2 | |
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD | 462 374.5 | -2 631.9 | -2 389.6 | -2 389.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
208.4B USD | 5.7 | 27 | 15.4 | 15.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.3B USD | 6.3 | 21.8 | 13.5 | 16.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
125.9B USD | 10.5 | 31.9 | 24.1 | 25.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD | 5.7 | 18.3 | 13.7 | 15.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
71.1B AUD | 3.2 | 16.7 | 11.5 | 14.3 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.9B EUR | 11.4 | 36.5 | 39.7 | 40.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
